For those of you who are interested, these are our learning objectives for Cerebrovascular Accident. We only had 2 days of lecture but alas the professor wrote the chapter about it in Koda-Kimball....
1. Distinguish between ischemic stroke, transient ischemic attack, reversible ischemic neurological deficit, subarachnoid hemorrhage, and hemorrhagic stroke when given a description of a patient?s symptoms and clinical presentation.
2. Collect the appropriate diagnostic information needed for the development of a pharmacotherapeutic plan.
3. Discuss the epidemiology, economics, and personal impact of cerebrovascular accidents.
4. Explain the pathophysiology of ischemic stroke and intracerebral hemorrhage and utilize these concepts in the development of a therapeutic regimen.
5. Develop treatment guidelines on the use of thrombolytic agents, antiplatelet agents, and anticoagulants, for patients with ischemic stroke.
6. Establish appropriate treatment goals and approaches of control of blood pressure control for patients with an ischemic or hemorrhagic stroke.
7. Develop an initiate a rational treatment plan for patients with a TIA, acute ischemic stroke, or subarachnoid hemorrhage.
8. Establish a treatment plan designed to prevent ischemic stroke in patients with atrial fibrillation, carotid artery stenosis, or vertebral-basilar artery stenosis.
9. Design a therapeutic monitoring plan for patients receiving antiplatelet agents, anticoagulants, or thrombolytic agents in the prevention or treatment of cerebrovascular disease.
10. Identify at least 3 major issues in the rehabilitation of patients who have experienced an ischemic or hemorrhagic stroke that involve or alter pharmaceutical care.
11. Develop a pharmaceutical care plan for patients with swalloing difficulties, neurogenic bladder, neurogenic bowel, and spasticity following an ischemic or hemorrhagic stroke.
1. Distinguish between ischemic stroke, transient ischemic attack, reversible ischemic neurological deficit, subarachnoid hemorrhage, and hemorrhagic stroke when given a description of a patient?s symptoms and clinical presentation.
2. Collect the appropriate diagnostic information needed for the development of a pharmacotherapeutic plan.
3. Discuss the epidemiology, economics, and personal impact of cerebrovascular accidents.
4. Explain the pathophysiology of ischemic stroke and intracerebral hemorrhage and utilize these concepts in the development of a therapeutic regimen.
5. Develop treatment guidelines on the use of thrombolytic agents, antiplatelet agents, and anticoagulants, for patients with ischemic stroke.
6. Establish appropriate treatment goals and approaches of control of blood pressure control for patients with an ischemic or hemorrhagic stroke.
7. Develop an initiate a rational treatment plan for patients with a TIA, acute ischemic stroke, or subarachnoid hemorrhage.
8. Establish a treatment plan designed to prevent ischemic stroke in patients with atrial fibrillation, carotid artery stenosis, or vertebral-basilar artery stenosis.
9. Design a therapeutic monitoring plan for patients receiving antiplatelet agents, anticoagulants, or thrombolytic agents in the prevention or treatment of cerebrovascular disease.
10. Identify at least 3 major issues in the rehabilitation of patients who have experienced an ischemic or hemorrhagic stroke that involve or alter pharmaceutical care.
11. Develop a pharmaceutical care plan for patients with swalloing difficulties, neurogenic bladder, neurogenic bowel, and spasticity following an ischemic or hemorrhagic stroke.